<DOC>
	<DOCNO>NCT01337479</DOCNO>
	<brief_summary>The purpose study follow patient treat entecavir Phase III rollover study safety experience Hepatitis B virus ( HBV ) -related complication .</brief_summary>
	<brief_title>A Phase IIIb : Long-Term Outcomes Hepatitis B ( HepB ) Patients Some Previous Entecavir ( ETV ) Trials</brief_title>
	<detailed_description>Observational Model : Only subject participated Entecavir Phase III study AI463022 , AI463023 , AI463026 , AI463027 . Number groups/cohorts : 1 ( All subject observe manner ) .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>All subject participate Entecavir Phase III study AI463022 , AI463023 , AI463026 , AI463027 .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>